Abstract
TO THE EDITOR: Roy et al. recently published a study adopting a standardized protocol of intravenous insulin administration to reduce glycemia in diabetic cancer patients undergoing 18F-FDG PET ( [1][1] ). The authors claimed that the pretest intravenous insulin injection in diabetic patients is a
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
